Riskpilot← Back to searchSign inGet full accessMIKIL HOLDING AS
ASActiveOrg 988964263Sørkedalsveien 10D, 0369 OsloOther human health activities n.e.c. · NACE 8699Est. 20060 employees
Revenue 2025
NOK 0
EBITDA margin
—
+95% vs 2024
Equity ratio
65.1%
Financial strength
Net profit 2025
NOK -27K
+80% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -5K | +95% |
| Net profit | NOK -27K | +80% |
| Total assets | NOK 5,9M | +0% |
| Equity | NOK 3,9M | -30% |
| Employees | 0 | — |
Legal name
MIKIL HOLDING AS
Org number
988964263
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
13. januar 2006
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Helsetjeneste, forskning og faglig utvikling, kjøp og salg av aksjer og deltagelse i andre virksomheter samt rådgivning.
Address
Sørkedalsveien 10D, 0369 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −70 | −42 | −58 | −97 | −5 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −70 | −42 | −58 | −97 | −5 |
| Net financials | 3 066 | 2 536 | −8 | −38 | −22 |
| Profit before tax | 2 996 | 2 493 | −66 | −135 | −27 |
| Tax | −1 | 765 | −0 | −0 | −0 |
| Net profit | 2 997 | 1 728 | −66 | −135 | −27 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 10 368 | 10 226 | 7 399 | 5 971 | 5 944 |
| Equity | 7 368 | 6 996 | 5 631 | 5 496 | 3 869 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 000 | 3 230 | 1 769 | 476 | 2 076 |
| Total debt | 3 000 | 3 230 | 1 769 | 476 | 2 076 |
EBITDA margin
-506500.0%
This company
15.8%
Market median
-3205796% vs market
20212025
Equity ratio
65.1%
This company
38.2%
Market median
+70% vs market
20212025
Return on equity
-0.7%
This company
18.4%
Market median
-104% vs market
20212025
Net profit margin
-2686400.0%
This company
8.1%
Market median
-33165532% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
BA Deputy Member | Deputy Member | 2006 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10% | 10% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MIKIL HOLDING AS (this company)
SYNAPSEKLINIKKEN ASBoard members of MIKIL HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Brita Aanes | Deputy Member | 0 companies |
| Silje Aanes Fagerlund | Board of Directors | 0 companies |
| Olav Aanes Fagerlund | Board of Directors | 0 companies |